Bamlanivimab for Covid-19 in Kidney Transplant Patients
Barriers to Living Kidney Donation: A Closer Look at Declined Donors
Baseline Levels of Dd-cf Dna After Pancreas Transplantation: Using Dd-cfdna as an Indicator for Pancreas Rejection and Biopsy Avoidance
Basiliximab versus Alemtuzumab: The Association Between Induction Agent and Airway Complications Following Lung Transplantation
Belatacept and Carfilzomib-based Treatment of Active Antibody-mediated Rejection in a Sensitized Nonhuman Primate Model
Belatacept and Rapamycin Maintenance Immunosuppression in a Sensitized Nonhuman Primate Kidney Allotransplantation Model
Belatacept Conversion in Elderly Renal Transplant Recipients
Belatacept Conversion in Proteinuric Renal Transplant Recipients: An Interventional Multi-Center Trial
Belatacept Exposure Not Associated With Rejection. Can Doses be Lowered without Compromising Efficacy?
Belatacept for Kidney Transplantation in the Age of Covid19, is it Safe?
- « Previous Page
- 1
- …
- 12
- 13
- 14
- 15
- 16
- …
- 139
- Next Page »